^
Association details:
| Biomarker: | TP53 mutation |
|---|---|
| Cancer: | Myelodysplastic Syndrome |
| Drug: | Orca-T (Immunomodulator) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
2230 High Disease-Free Survival in Patients with High-Risk MDS Treated with Orca-T
Published date:
11/02/2023
Excerpt:
In this phase 1b study, Orca-T was evaluated in MDS patients...one MDS patient with very poor prognosis, characterized by mutated TP53 and complex karyotype, remains in CR…
